|
|
|
|
||||||||||
|
ChiRhoClin,
Inc., a Maryland
based corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin
is a research and development oriented pharmaceutical company focused on
the development of peptide and protein based drug products. ChiRhoClin, Inc also provides contract services to the pharmaceutical industry in areas including regulatory support, clinical and medical monitoring, report writing, safety surveillance, pharmacokinetics, pharmacodynamics and biostatistics.
ChiRhoClin received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin. Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market Synthetic Human Secretin.
ChiRhoClin mission is to develop high quality peptide and protein based drug products.
Contact Information
ChiRhoClin, Inc. 4000 Blackburn La suite 270 Burtonsville MD, 20866 301-476-8388 Fax: 301-476-9529 Email: ChiRhoClin@ChiRhoClin.com
|
|
||||||||||
|